Novo Nordisk A/S (NVO) short interest & options flow
NYSENVO short sellers have added roughly 40% more shares since late September, pushing borrowed positions to their highest level in at least a year at 37.8 million shares, even as the stock has edged up 4.4% over the past month to $40. The borrowing build is the clearest pre-earnings signal in the data. Short positions were largely flat through most of September and into early October…
NVO short interest surges 21.5% in one week to 32.9M shares, as cost to borrow plummets 53% to 0.23%.
- Market cap
- $179.56B
- Next earnings
- 3 Feb 2027
Key data as of 12 Nov 2026
NVO news and analysis
RSSNo long-form analysis yet for NVO. Pulse alerts and the live data picture are available on ORTEX.
Open NVO on ORTEX →Want the live picture for NVO?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NVO — free to start on ORTEX.
Sign up for free →Open NVO on ORTEX